BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33819276)

  • 21. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doubly robust estimation of the weighted average treatment effect for a target population.
    Tao Y; Fu H
    Stat Med; 2019 Feb; 38(3):315-325. PubMed ID: 30302780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weighted estimation for confounded binary outcomes subject to misclassification.
    Gravel CA; Platt RW
    Stat Med; 2018 Feb; 37(3):425-436. PubMed ID: 29082530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes.
    Burgess S; Thompson SG
    Stat Med; 2012 Jul; 31(15):1582-600. PubMed ID: 22374818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two basic statistical strategies of conducting causal inference in real-world studies.
    Fang Y
    Contemp Clin Trials; 2020 Dec; 99():106193. PubMed ID: 33153972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclassification estimation of the weighted average treatment effect.
    Choi BY
    Biom J; 2021 Dec; 63(8):1706-1728. PubMed ID: 34270815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.
    Dharmarajan SH; Li Y; Lehmann D; Schaubel DE
    Biom J; 2021 Apr; 63(4):712-724. PubMed ID: 33346382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias.
    Pressler TR; Kaizar EE
    Stat Med; 2013 Sep; 32(20):3552-68. PubMed ID: 23553373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causal inference accounting for unobserved confounding after outcome regression and doubly robust estimation.
    Genbäck M; de Luna X
    Biometrics; 2019 Jun; 75(2):506-515. PubMed ID: 30430543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events.
    Lou Y; Jones MP; Sun W
    Stat Med; 2019 Nov; 38(27):5214-5235. PubMed ID: 31621943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating effects of nursing intervention via propensity score analysis.
    Qin R; Titler MG; Shever LL; Kim T
    Nurs Res; 2008; 57(6):444-52. PubMed ID: 19018219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tutorial on the use of instrumental variables in pharmacoepidemiology.
    Ertefaie A; Small DS; Flory JH; Hennessy S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):357-367. PubMed ID: 28239929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical approaches for enhancing causal interpretation of the M to Y relation in mediation analysis.
    MacKinnon DP; Pirlott AG
    Pers Soc Psychol Rev; 2015 Feb; 19(1):30-43. PubMed ID: 25063043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single proxy control.
    Park C; Richardson DB; Tchetgen Tchetgen EJ
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38646999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the ability of double-robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study.
    Nguyen TL; Collins GS; Spence J; Devereaux PJ; Daurès JP; Landais P; Le Manach Y
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1513-1519. PubMed ID: 28984050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to treatment effect heterogeneity in the presence of confounding.
    Anoke SC; Normand SL; Zigler CM
    Stat Med; 2019 Jul; 38(15):2797-2815. PubMed ID: 30931547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research.
    Stuart EA; Lee BK; Leacy FP
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S84-S90.e1. PubMed ID: 23849158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confounding-adjustment methods for the causal difference in medians.
    Shepherd DA; Baer BR; Moreno-Betancur M
    BMC Med Res Methodol; 2023 Dec; 23(1):288. PubMed ID: 38062364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.